← Back to Search

Biofilm Disruptor

BLASTX Lubricated Catheter for Urinary Tract Infection

N/A
Waitlist Available
Research Sponsored by Next Science TM
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

Study Summary

This trial will study the effectiveness of a new lubricant gel for catheters.

Eligible Conditions
  • Urinary Tract Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Catheter microorganisms DNA analysis
Urine microorganisms DNA analysis
Secondary outcome measures
Incidence of Urinary Tract Infections (UTIs)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BLASTX Lubricated CatheterExperimental Treatment1 Intervention
Subjects for which catheterization is prescribed will be catheterized with a Foley lubricated with BLASTX. This gel lubricates with the same viscosity as McKesson Jelly and has a biofilm disruptive active ingredient.
Group II: McKesson Jelly Lubricated CatheterPlacebo Group1 Intervention
Subjects for which catheterization is prescribed will be catheterized with a Foley lubricated with McKesson Jelly. This jelly lubricates with the same viscosity as BLASTX but has no biofilm disruptive active ingredient.

Find a Location

Who is running the clinical trial?

Next Science TMLead Sponsor
15 Previous Clinical Trials
9,509 Total Patients Enrolled
American Medical Research InstituteUNKNOWN
Susan Greco, MDStudy DirectorNext Science
1 Previous Clinical Trials
68 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Efficacy of BLASTX in Catheter Associated Bacteriuria Versus Standard of Care (SOC)
2017. "Efficacy of BLASTX in Catheter Associated Bacteriuria Versus Standard of Care (SOC)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03176394.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top